Characterization of hiPSC-neurons from psychosis patients with neurexin-1 deletions
Neurexin-1 缺失精神病患者 hiPSC 神经元的表征
基本信息
- 批准号:9328489
- 负责人:
- 金额:$ 4.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-04 至 2020-04-03
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingAnimal ModelBehaviorBipolar DisorderCell Adhesion MoleculesCell LineClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDelusionsEngineeringExhibitsExonsFoundationsGene ExpressionGeneticGenetic RiskGenetic TranscriptionGenomeGoalsHallucinationsHeritabilityHumanIndividualLinkMediatingMessenger RNAModelingMolecularMorphologyMusMutationNeurodevelopmental DisorderNeuronsPatientsPatternPenetrancePhenotypePopulationPrefrontal CortexProtein IsoformsPsychotic DisordersRNA SplicingRiskRoleSchizophreniaSymptomsSynaptic TransmissionTestingTimeTissue-Specific Gene ExpressionTranscriptUp-RegulationWorkautism spectrum disorderbaseclinical Diagnosiscohortdifferential expressionexcitatory neuronexperienceexperimental studygenetic risk factorgenetic variantimprovedinduced pluripotent stem cellneuropsychiatric disorderneuropsychiatric symptomneurotransmitter releasenovelnucleasepresynapticrisk variantsmall moleculesynaptic functiontargeted sequencing
项目摘要
Project Summary
Heterozygous deletion of neurexin-1 (NRXN1), a presynaptic cell adhesion molecule, is strongly associated with
neuropsychiatric disorders and psychosis. NRXN1 is highly alternatively spliced and recently a role for these
splice isoforms in neuronal identity has been suggested; however, NRXN1 isoforms have not been characterized
in human neurons. Animal models of NRXN1 deletion display deficits in behavior and neuronal activity. However,
animal models cannot recapitulate the effect of myriad patient-specific deletions in the context of other risk
variants within a patient’s genome; together, these effects likely influence the variable penetrance of NRXN1
deletions, which confer a diverse set of clinical diagnoses. Using hiPSC-neurons derived from a rare cohort of
four psychosis patients carrying NRXN1 deletions, this proposal will investigate the casual contribution of these
deletions on gene expression, alternative splicing and neuronal phenotypes in excitatory hiPSC-neurons. There
are three aims: the first is identify differences in alternative splicing in NRXN1 deletion hiPSC-neurons, the
second is to restore isoform deficiencies and manipulate NRXN1 expression in hiPSC-neurons, and the third is
to establish the functional significance of NRXN1 deletion in hiPSC-neurons. My hypothesis is that excitatory
hiPSC-neurons derived from four psychosis patients will exhibit differential expression of NRXN1 isoforms which
are crucial for proper neuronal activity and morphology. We include strong preliminary data demonstrating the
feasibility of our proposal; moreover, we have already observed that NRXN1 hiPSC-neurons express both
wildtype and deleted allele variants. Our hope is that these experiments will improve our understanding of the
molecular mechanisms underlying genetic risk for neuropsychiatric disorders.
项目摘要
神经氧蛋白1(NRXN1)的杂合缺失,一种突触前细胞粘附分子,与
神经精神疾病和精神病。 NRXN1是高度剪接的,最近是这些作用
已经提出了在神经元同一性中的剪接同工型。但是,尚未表征NRXN1同工型
在人类神经元中。 NRXN1缺失显示的动物模型在行为和神经元活动中定义。然而,
动物模型无法在其他风险的情况下概括众多患者特定缺失的影响
患者基因组中的变体;这些效果在一起可能会影响NRXN1的可变渗透率
删除,会议会议一组各种临床诊断。使用来自稀有队列的HIPSC-神经元
四名携带NRXN1缺失的精神病患者,该提案将调查这些建议的随意贡献
兴奋性HIPSC-神经元中的基因表达,替代剪接和神经元表型的缺失。那里
是三个目的:第一个是识别NRXN1删除HIPSC-NERORS中替代剪接的差异,
其次是恢复同工型缺陷并操纵HIPSC-神经元中的NRXN1表达,第三个是
建立hipsc-神经元中NRXN1缺失的功能意义。我的假设是兴奋性
来自四名精神病患者的HIPSC-神经元将表现出NRXN1同工型的差异表达,这些表达
对于适当的神经元活性和形态至关重要。我们包括强大的初步数据,证明
我们的提议的可行性;此外,我们已经观察到NRXN1 HIPSC-Neurons表达
野生型和删除的等位基因变体。我们希望这些实验将提高我们对
神经精神疾病的遗传风险的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin Flaherty其他文献
Erin Flaherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin Flaherty', 18)}}的其他基金
The role of the protocadherin gene cluster in neurodevelopment and the implications for neurodevelopmental disorders
原钙粘蛋白基因簇在神经发育中的作用及其对神经发育障碍的影响
- 批准号:
10808516 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
- 批准号:81071809
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
- 批准号:30971223
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Uncovering the role of SAP97 in synaptic function and schizophrenia.
揭示 SAP97 在突触功能和精神分裂症中的作用。
- 批准号:
10736790 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Pharmacodynamic Biomarker of Myotonic Dystrophy
强直性肌营养不良的药效生物标志物
- 批准号:
10651049 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Validation of a novel tau clearance mechanism.
验证新型 tau 清除机制。
- 批准号:
10445826 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Transposable Element Interaction and Its Impact on Human Development and Health
转座元件相互作用及其对人类发育和健康的影响
- 批准号:
10705110 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别: